232 related articles for article (PubMed ID: 29464314)
61. Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate.
Harley CR; Frytak JR; Tandon N
Am J Manag Care; 2003 Oct; 9(6 Suppl):S136-43. PubMed ID: 14577718
[TBL] [Abstract][Full Text] [Related]
62. High serum level of haptoglobin is associated with the response of 12 weeks methotrexate therapy in recent-onset rheumatoid arthritis patients.
Tan W; Wang F; Guo D; Ke Y; Shen Y; Lv C; Zhang M
Int J Rheum Dis; 2016 May; 19(5):482-9. PubMed ID: 24863583
[TBL] [Abstract][Full Text] [Related]
63. Infliximab-induced lupus or rheumatoid arthritis (RA) overlapping with systemic lupus erythematosus (SLE) unmasked by infliximab.
Novak S; Cikes N
Clin Exp Rheumatol; 2004; 22(2):268. PubMed ID: 15083903
[No Abstract] [Full Text] [Related]
64. Infliximab but not methotrexate induces extra-high levels of VLDL-triglyceride in patients with rheumatoid arthritis.
Saiki O; Takao R; Naruse Y; Kuhara M; Imai S; Uda H
J Rheumatol; 2007 Oct; 34(10):1997-2004. PubMed ID: 17787045
[TBL] [Abstract][Full Text] [Related]
65. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
66. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
[TBL] [Abstract][Full Text] [Related]
67. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial.
van Vollenhoven RF; Ernestam S; Geborek P; Petersson IF; Cöster L; Waltbrand E; Zickert A; Theander J; Thörner A; Hellström H; Teleman A; Dackhammar C; Akre F; Forslind K; Ljung L; Oding R; Chatzidionysiou A; Wörnert M; Bratt J
Lancet; 2009 Aug; 374(9688):459-66. PubMed ID: 19665644
[TBL] [Abstract][Full Text] [Related]
68. Infliximab efficacy in rheumatoid arthritis after an inadequate response to etanercept or adalimumab: results of a target-driven active switch study.
Fleischmann R; Goldman JA; Leirisalo-Repo M; Zanetakis E; El-Kadi H; Kellner H; Bolce R; DeHoratius R; Wang J; Decktor D
Curr Med Res Opin; 2014 Nov; 30(11):2139-49. PubMed ID: 25050591
[TBL] [Abstract][Full Text] [Related]
69. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
[TBL] [Abstract][Full Text] [Related]
70. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis.
Wittkowski H; Foell D; af Klint E; De Rycke L; De Keyser F; Frosch M; Ulfgren AK; Roth J
Ann Rheum Dis; 2007 Aug; 66(8):1020-5. PubMed ID: 17223658
[TBL] [Abstract][Full Text] [Related]
71. [Infliximab in the treatment of rheumatoid arthritis].
Akahoshi T; Watabe H
Nihon Rinsho; 2002 Dec; 60(12):2378-83. PubMed ID: 12510365
[TBL] [Abstract][Full Text] [Related]
72. Improved response to infliximab after leukocytapheresis in a patent with rheumatoid arthritis.
Azuma T; Ishimaru H; Hatta K; Kori Y
Mod Rheumatol; 2007; 17(3):253-5. PubMed ID: 17564785
[TBL] [Abstract][Full Text] [Related]
73. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
[TBL] [Abstract][Full Text] [Related]
74. [Efficacy and safety of infliximab in patients with rheumatoid arthritis].
Zhang W; Shi Q; Wu DH; Bao CD; Yang NP; Li ZG; Zhu P; Zhang X; Huang CB; He DY; Ye ZZ; Tao Y; Fang YF; Gu JR; Wu HX; Sun LY; Yang XY; Huang F; Xu HJ; Zhao DB; Zhang MJ; Zheng Y; Ai MX; Lu J; Zhang FC
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(27):1876-80. PubMed ID: 19953907
[TBL] [Abstract][Full Text] [Related]
75. Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.
Tasaki S; Suzuki K; Kassai Y; Takeshita M; Murota A; Kondo Y; Ando T; Nakayama Y; Okuzono Y; Takiguchi M; Kurisu R; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Toyoshiba H; Takeuchi T
Nat Commun; 2018 Jul; 9(1):2755. PubMed ID: 30013029
[TBL] [Abstract][Full Text] [Related]
76. Effects of methotrexate, sulphasalazine and aurothiomalate on polymorphonuclear leucocytes in rheumatoid arthritis.
Storgaard M; Jensen MP; Stengaard-Pedersen K; Møller BK; Anderson PL; Obel N
Scand J Rheumatol; 1996; 25(3):168-73. PubMed ID: 8668961
[TBL] [Abstract][Full Text] [Related]
77. The Impact of Early Optimization of Infliximab Blood Concentrations >1 μg/mL on Therapeutic Effectiveness in Rheumatoid Arthritis.
Nozaki Y; Kotani T; Takeuchi T; Hidaka T; Miyake H; Hatta K; Kurosawa Y; Sudo M; Ito S; Kinoshita K; Matsumura I
Front Biosci (Landmark Ed); 2023 Apr; 28(4):68. PubMed ID: 37114546
[TBL] [Abstract][Full Text] [Related]
78. Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.
Anand D; Kumar U; Kanjilal M; Kaur S; Das N
Clin Exp Immunol; 2014 Jun; 176(3):327-35. PubMed ID: 24433281
[TBL] [Abstract][Full Text] [Related]
79. The effect of infliximab on antiviral antibody profiles in patients with rheumatoid arthritis.
Kaufman I; Moscovici YB; Abudi Y; Sofer D; Mendelson E; Balbir-Gurman A; Caspi D; Elkayam O
Rheumatol Int; 2010 Jan; 30(3):325-9. PubMed ID: 19455337
[TBL] [Abstract][Full Text] [Related]
80. Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent.
Elmgreen J; Hansen TM
Ann Rheum Dis; 1985 Aug; 44(8):514-8. PubMed ID: 4026413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
